vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and AMREP CORP. (AXR). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $14.6M, roughly 1.3× AMREP CORP.). AMREP CORP. runs the higher net margin — 21.6% vs -6.8%, a 28.4% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs 34.7%). AMREP CORP. produced more free cash flow last quarter ($5.4M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -13.6%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.
APYX vs AXR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $14.6M |
| Net Profit | $-1.3M | $3.1M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 20.6% |
| Net Margin | -6.8% | 21.6% |
| Revenue YoY | 34.7% | 93.8% |
| Net Profit YoY | 71.9% | 338.9% |
| EPS (diluted) | — | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $14.6M | ||
| Q4 25 | $19.2M | $9.4M | ||
| Q3 25 | $12.9M | $17.9M | ||
| Q2 25 | $11.4M | $11.2M | ||
| Q1 25 | $9.4M | $7.5M | ||
| Q4 24 | $14.2M | $11.9M | ||
| Q3 24 | $11.5M | $19.1M | ||
| Q2 24 | $12.1M | $19.5M |
| Q1 26 | — | $3.1M | ||
| Q4 25 | $-1.3M | $1.2M | ||
| Q3 25 | $-2.0M | $4.7M | ||
| Q2 25 | $-3.8M | $3.9M | ||
| Q1 25 | $-4.2M | $717.0K | ||
| Q4 24 | $-4.6M | $4.0M | ||
| Q3 24 | $-4.7M | $4.1M | ||
| Q2 24 | $-6.6M | $4.1M |
| Q1 26 | — | — | ||
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — |
| Q1 26 | — | 20.6% | ||
| Q4 25 | 0.1% | 11.9% | ||
| Q3 25 | -6.5% | 34.4% | ||
| Q2 25 | -22.6% | 31.7% | ||
| Q1 25 | -32.4% | 5.7% | ||
| Q4 24 | -21.4% | 26.4% | ||
| Q3 24 | -31.6% | 26.1% | ||
| Q2 24 | -45.7% | 23.9% |
| Q1 26 | — | 21.6% | ||
| Q4 25 | -6.8% | 12.8% | ||
| Q3 25 | -15.4% | 26.3% | ||
| Q2 25 | -33.2% | 34.8% | ||
| Q1 25 | -44.0% | 9.5% | ||
| Q4 24 | -32.5% | 33.9% | ||
| Q3 24 | -40.9% | 21.3% | ||
| Q2 24 | -54.0% | 21.2% |
| Q1 26 | — | $0.58 | ||
| Q4 25 | — | $0.22 | ||
| Q3 25 | — | $0.87 | ||
| Q2 25 | — | $0.73 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $0.75 | ||
| Q3 24 | — | $0.76 | ||
| Q2 24 | $-0.19 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $50.0M |
| Total DebtLower is stronger | $37.5M | $21.0K |
| Stockholders' EquityBook value | $14.5M | $139.4M |
| Total Assets | $66.8M | $143.9M |
| Debt / EquityLower = less leverage | 2.58× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $50.0M | ||
| Q4 25 | $31.7M | $44.6M | ||
| Q3 25 | $25.1M | $48.9M | ||
| Q2 25 | $29.3M | $39.5M | ||
| Q1 25 | $31.0M | $36.9M | ||
| Q4 24 | $31.7M | $40.1M | ||
| Q3 24 | $28.0M | $40.4M | ||
| Q2 24 | $32.7M | $29.7M |
| Q1 26 | — | $21.0K | ||
| Q4 25 | $37.5M | $23.0K | ||
| Q3 25 | $37.5M | $25.0K | ||
| Q2 25 | $37.5M | $26.0K | ||
| Q1 25 | $37.5M | $29.0K | ||
| Q4 24 | $37.5M | $32.0K | ||
| Q3 24 | $37.5M | $34.0K | ||
| Q2 24 | — | $35.0K |
| Q1 26 | — | $139.4M | ||
| Q4 25 | $14.5M | $136.0M | ||
| Q3 25 | $5.8M | $134.7M | ||
| Q2 25 | $7.3M | $130.0M | ||
| Q1 25 | $10.5M | $126.0M | ||
| Q4 24 | $14.2M | $125.1M | ||
| Q3 24 | $11.0M | $122.2M | ||
| Q2 24 | $14.7M | $118.0M |
| Q1 26 | — | $143.9M | ||
| Q4 25 | $66.8M | $140.1M | ||
| Q3 25 | $57.4M | $140.7M | ||
| Q2 25 | $58.2M | $133.8M | ||
| Q1 25 | $60.2M | $128.9M | ||
| Q4 24 | $64.8M | $129.1M | ||
| Q3 24 | $60.7M | $127.0M | ||
| Q2 24 | $65.4M | $122.8M |
| Q1 26 | — | 0.00× | ||
| Q4 25 | 2.58× | 0.00× | ||
| Q3 25 | 6.41× | 0.00× | ||
| Q2 25 | 5.17× | 0.00× | ||
| Q1 25 | 3.57× | 0.00× | ||
| Q4 24 | 2.64× | 0.00× | ||
| Q3 24 | 3.40× | 0.00× | ||
| Q2 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $5.4M |
| Free Cash FlowOCF − Capex | $-2.8M | $5.4M |
| FCF MarginFCF / Revenue | -14.6% | 37.0% |
| Capex IntensityCapex / Revenue | 1.4% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $20.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.4M | ||
| Q4 25 | $-2.5M | $-4.3M | ||
| Q3 25 | $-3.5M | $9.5M | ||
| Q2 25 | $-1.2M | $10.2M | ||
| Q1 25 | $-702.0K | $-3.2M | ||
| Q4 24 | $-2.9M | $-182.0K | ||
| Q3 24 | $-4.4M | $10.7M | ||
| Q2 24 | $-4.3M | $10.7M |
| Q1 26 | — | $5.4M | ||
| Q4 25 | $-2.8M | $-4.3M | ||
| Q3 25 | $-4.1M | $9.5M | ||
| Q2 25 | $-1.5M | $9.7M | ||
| Q1 25 | $-757.0K | $-3.3M | ||
| Q4 24 | $-3.2M | $-268.0K | ||
| Q3 24 | $-4.6M | $10.7M | ||
| Q2 24 | $-4.6M | $10.3M |
| Q1 26 | — | 37.0% | ||
| Q4 25 | -14.6% | -45.9% | ||
| Q3 25 | -31.5% | 53.2% | ||
| Q2 25 | -13.2% | 86.4% | ||
| Q1 25 | -8.0% | -43.4% | ||
| Q4 24 | -22.4% | -2.3% | ||
| Q3 24 | -40.0% | 55.8% | ||
| Q2 24 | -38.0% | 52.5% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | 1.4% | 0.6% | ||
| Q3 25 | 4.0% | 0.1% | ||
| Q2 25 | 2.3% | 5.2% | ||
| Q1 25 | 0.6% | 0.3% | ||
| Q4 24 | 1.7% | 0.7% | ||
| Q3 24 | 1.3% | 0.2% | ||
| Q2 24 | 2.4% | 2.3% |
| Q1 26 | — | 1.72× | ||
| Q4 25 | — | -3.54× | ||
| Q3 25 | — | 2.03× | ||
| Q2 25 | — | 2.63× | ||
| Q1 25 | — | -4.51× | ||
| Q4 24 | — | -0.05× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 2.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
